Clinical Research Directory
Browse clinical research sites, groups, and studies.
Impact of Telepharmacy on Hemodialysis Outcomes
Sponsor: Damanhour University
Summary
This study looked at whether regular follow-up by pharmacists through phone calls (telepharmacy) can help improve the treatment of anaemia in patients undergoing haemodialysis. Anaemia is very common in patients with kidney disease and can cause fatigue, weakness, and an increased risk of heart problems. It is usually treated with medications such as erythropoietin (EPO), but managing the correct dose and ensuring patients follow treatment can be challenging. In this study, patients were divided into two groups. One group received standard care, while the other group received additional support from pharmacists through regular phone calls. During these calls, pharmacists helped patients understand their medications, encouraged adherence, monitored symptoms, and worked with doctors to adjust treatment when needed.
Official title: Effect of Telepharmacy on Clinical and Economic Outcomes in Hemodialysis Patients: A Randomized Controlled Trial
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
101
Start Date
2024-12-01
Completion Date
2025-04-30
Last Updated
2026-10-22
Healthy Volunteers
No
Conditions
Interventions
Routine Standard Care
Participants assigned to the Routine Standard Care intervention received routine maintenance hemodialysis care according to the participating hospitals' standard clinical practice. Standard care included regular nephrologist follow-up, routine laboratory monitoring (including hemoglobin and other relevant biochemical parameters), prescription and adjustment of erythropoiesis-stimulating agents (ESAs) and other medications as clinically indicated, and conventional nursing and dialysis care. Medication management and treatment decisions were made during routine clinical visits. Unlike the experimental arm, participants did not receive the structured telepharmacy intervention, including scheduled telephone consultations, proactive medication review, adherence counseling, pharmacist-initiated remote monitoring, or pharmacist-led therapeutic follow-up.
Telepharmacy Intervention
Pharmacist-led remote care including scheduled telephone follow-up, medication review, adherence assessment, individualized counseling, monitoring of laboratory results, identification and resolution of drug-related problems, and collaboration with physicians to optimize erythropoiesis-stimulating agent (ESA) therapy and overall medication management. Participants continued to receive routine standard care throughout the study in addition to the telepharmacy intervention.
Locations (2)
Menoufia University Hospital
Shibīn al Kawm, Menofia, Egypt
Menoufia University Hospital
Shibīn al Kawm, Menoufia, Egypt